T3 affects expression of collagen I and collagen cross-linking in bone cell cultures

Biochemical and Biophysical Research Communications

Volumn 402, Issue 2, 2010, Pages 180-185

  Varga, F ^a   Rumpler, M ^a   Zoehrer, R ^b   Turecek, C ^a   Spitzer, S ^a   Thaler, R ^a   Paschalis, E P ^a   Klaushofer, K ^a  

^a HANUSCH HOSPITAL   (Austria)

^b FLINDERS UNIVERSITY   (Australia)

Author keywords

Bone matrix quality; Collagen cross linking; Gene expression; Osteoblast; Thyroid hormones

Indexed keywords

COLLAGEN TYPE 1; DIOXYGENASE; MESSENGER RNA; PROCOLLAGEN; PROCOLLAGEN C PROTEINASE; PROCOLLAGEN LYSINE 1,2 OXOGLUTARATE 5DIOXYGENASE 2; THYROID HORMONE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE CELL; CELL CULTURE; COLLAGEN SYNTHESIS; CROSS LINKING; DOSE RESPONSE; GENE EXPRESSION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN SYNTHESIS; TIME; UPREGULATION;

ANIMALS; CELL LINE; COLLAGEN TYPE I; MICE; OSTEOBLASTS; OSTEOGENESIS; TRIIODOTHYRONINE;

EID: 78149465972     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2010.08.022     Document Type: Article

References (46)

1. Murphy E., Williams G.R. The thyroid and the skeleton. Clin. Endocrinol. (Oxf.) 2004, 61:285-298.
2. Allain T.J., McGregor A.M. Thyroid hormones and bone. J. Endocrinol. 1993, 139:9-18.
3. Gothe S., Wang Z., Ng L., Kindblom J.M., Barros A.C., Ohlsson C., Vennstrom B., Forrest D. Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev. 1999, 13:1329-1341.
4. Nilsson O., Marino R., De Luca F., Phillip M., Baron J. Endocrine regulation of the growth plate. Horm. Res. 2005, 64:157-165.
5. Harvey C.B., O'Shea P.J., Scott A.J., Robson H., Siebler T., Shalet S.M., Samarut J., Chassande O., Williams G.R. Molecular mechanisms of thyroid hormone effects on bone growth and function. Mol. Genet. Metab. 2002, 75:17-30.
6. Varga F., Rumpler M., Luegmayr E., Fratzl Z.N., Glantschnig H., Klaushofer K. Triiodothyronine, a regulator of osteoblastic differentiation: depression of histone H4, attenuation of c-fos/c-jun, and induction of osteocalcin expression. Calcif. Tissue Int. 1997, 61:404-411.
7. Varga F., Spitzer S., Klaushofer K. Triiodothyronine (T3) and 1,25-dihydroxyvitamin D3 (1,25D3) inversely regulate OPG gene expression in dependence of the osteoblastic phenotype. Calcif. Tissue Int. 2004, 74:382-387.
8. Fratzl-Zelman N., Glantschnig H., Rumpler M., Nader A., Ellinger A., Varga F. The expression of matrix metalloproteinase-13 and osteocalcin in mouse osteoblasts is related to osteoblastic differentiation and is modulated by 1,25-dihydroxyvitamin D3 and thyroid hormones. Cell Biol. Int. 2003, 27:459-468.
9. Pereira R.C., Jorgetti V., Canalis E. Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts. Am. J. Physiol. 1999, 277:E496-E504.
10. Streuli C. Extracellular matrix remodelling and cellular differentiation. Curr. Opin. Cell Biol. 1999, 11:634-640.
11. Moursi A.M., Damsky C.H., Lull J., Zimmerman D., Doty S.B., Aota S., Globus R.K. Fibronectin regulates calvarial osteoblast differentiation. J. Cell Sci. 1996, 1369-1380.
12. Turecek C., Fratzl-Zelman N., Rumpler M., Buchinger B., Spitzer S., Zoehrer R., Durchschlag E., Klaushofer K., Paschalis E.P., Varga F. Collagen cross-linking influences osteoblastic differentiation. Calcif. Tissue Int. 2008, 82:392-400.
13. Kagan H.M., Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J. Cell Biochem. 2003, 88:660-672.
14. Liu G., Nellaiappan K., Kagan H.M. Irreversible inhibition of lysyl oxidase by homocysteine thiolactone and its selenium and oxygen analogues. Implications for homocystinuria. J. Biol. Chem. 1997, 272:32370-32377.
15. Oxlund H., Mosekilde L., Ortoft G. Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone 1996, 19:479-484.
16. Herrmann W. Significance of hyperhomocysteinemia. Clin. Lab. 2006, 52:367-374.
17. Blouin S., Thaler H.W., Korninger C., Schmid R., Hofstaetter J.G., Zoehrer R., Phipps R., Klaushofer K., Roschger P., Paschalis E.P. Bone matrix quality and plasma homocysteine levels. Bone 2009, 44:959-964.
18. van Meurs J.B., Dhonukshe-Rutten R.A., Pluijm S.M., van der Klift M., de Jonge R., Lindemans J., de Groot L.C., Hofman A., Witteman J.C., van Leeuwen J.P., Breteler M.M., Lips P., Pols H.A., Uitterlinden A.G. Homocysteine levels and the risk of osteoporotic fracture. N. Engl. J. Med. 2004, 350:2033-2041.
19. Thaler R., Spitzer S., Rumpler M., Fratzl-Zelman N., Klaushofer K., Paschalis E.P., Varga F. Differential effects of homocysteine and beta aminopropionitrile on preosteoblastic MC3T3-E1 cells. Bone 2009, 46:703-709.
20. Nagaoka H., Mochida Y., Atsawasuwan P., Kaku M., Kondoh T., Yamauchi M. 1,25(OH)2D3 regulates collagen quality in an osteoblastic cell culture system. Biochem. Biophys. Res. Commun. 2008, 377:674-678.
21. Shi Y.C., Worton L., Esteban L., Baldock P., Fong C., Eisman J.A., Gardiner E.M. Effects of continuous activation of vitamin D and Wnt response pathways on osteoblastic proliferation and differentiation. Bone 2007, 41:87-96.
22. Williams G.R., Robson H., Shalet S.M. Thyroid hormone actions on cartilage and bone: interactions with other hormones at the epiphyseal plate and effects on linear growth. J. Endocrinol. 1998, 157:391-403.
23. Mahonen A., Jukkola A., Risteli L., Risteli J., Maenpaa P.H. Type I procollagen synthesis is regulated by steroids and related hormones in human osteosarcoma cells. J. Cell Biochem. 1998, 68:151-163.
24. Varga F., Spitzer S., Rumpler M., Klaushofer K. 1,25-Dihydroxyvitamin D3 inhibits thyroid hormone-induced osteocalcin expression in mouse osteoblast-like cells via a thyroid hormone response element. J. Mol. Endocrinol. 2003, 30:49-57.
25. Varga F., Rumpler M., Spitzer S., Karlic H., Klaushofer K. Osteocalcin attenuates T3- and increases vitamin D3-induced expression of MMP-13 in mouse osteoblasts. Endocr. J. 2009, 56:441-450.
26. Peterkofsky B., Diegelmann R. Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 1971, 10:988-994.
27. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, CA) 2001, 25:402-408.
28. Paschalis E.P., Verdelis K., Doty S.B., Boskey A.L., Mendelsohn R., Yamauchi M. Spectroscopic characterization of collagen cross-links in bone. J. Bone Miner. Res. 2001, 16:1821-1828.
29. Luegmayr E., Varga F., Frank T., Roschger P., Klaushofer K. Effects of triiodothyronine on morphology, growth behavior, and the actin cytoskeleton in mouse osteoblastic cells (MC3T3-E1). Bone 1996, 18:591-599.
30. Fratzl-Zelman N., Horandner H., Luegmayr E., Varga F., Ellinger A., Erlee M.P., Klaushofer K. Effects of triiodothyronine on the morphology of cells and matrix, the localization of alkaline phosphatase, and the frequency of apoptosis in long-term cultures of MC3T3-E1 cells. Bone 1997, 20:225-236.
31. Varga F., Luegmayr E., Fratzl-Zelman N., Glantschnig H., Ellinger A., Prinz D., Rumpler M., Klaushofer K. Tri-iodothyronine inhibits multilayer formation of the osteoblastic cell line, MC3T3-E1, by promoting apoptosis. J. Endocrinol. 1999, 160:57-65.
32. Kasono K., Sato K., Han D.C., Fujii Y., Tsushima T., Shizume K. Stimulation of alkaline phosphatase activity by thyroid hormone in mouse osteoblast-like cells (MC3T3-E1): a possible mechanism of hyperalkaline phosphatasia in hyperthyroidism. Bone Miner. 1988, 4:355-363.
33. Sato K., Han D.C., Fujii Y., Tsushima T., Shizume K. Thyroid hormone stimulates alkaline phosphatase activity in cultured rat osteoblastic cells (ROS 17/2.8) through 3,5,3'-triiodo-l-thyronine nuclear receptors. Endocrinology 1987, 120:1873-1881.
34. Schmid C., Schlapfer I., Futo E., Waldvogel M., Schwander J., Zapf J., Froesch E.R. Triiodothyronine (T3) stimulates insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-2 production by rat osteoblasts in vitro. Acta Endocrinol. Copenh. 1992, 126:467-473.
35. Williams G.R., Bland R., Sheppard M.C. Retinoids modify regulation of endogenous gene expression by vitamin D3 and thyroid hormone in three osteosarcoma cell lines. Endocrinology 1995, 136:4304-4314.
36. Klaushofer K., Varga F., Glantschnig H., Fratzl-Zelman N., Czerwenka E., Leis H.J., Koller K., Peterlik M. The regulatory role of thyroid hormones in bone cell growth and differentiation. J. Nutr. 1995, 125:1996S-2003S.
37. Greenspan S.L., Greenspan F.S. The effect of thyroid hormone on skeletal integrity. Ann. Intern. Med. 1999, 130:750-758.
38. Shao Y.Y., Wang L., Ballock R.T. Thyroid hormone and the growth plate. Rev. Endocr. Metab. Disord. 2006, 7:265-271.
39. O'Shea P.J., Williams G.R. Insight into the physiological actions of thyroid hormone receptors from genetically modified mice. J. Endocrinol. 2002, 175:553-570.
40. Margolis D.S., Szivek J.A., Lai L.W., Lien Y.H. Phenotypic characteristics of bone in carbonic anhydrase II-deficient mice. Calcif. Tissue Int. 2008, 82:66-76.
41. Britto J.M., Fenton A.J., Holloway W.R., Nicholson G.C. Osteoblasts mediate thyroid hormone stimulation of osteoclastic bone resorption. Endocrinology 1994, 134:169-176.
42. Klaushofer K., Hoffmann O., Gleispach H., Leis H.J., Czerwenka E., Koller K., Peterlik M. Bone-resorbing activity of thyroid hormones is related to prostaglandin production in cultured neonatal mouse calvaria. J. Bone Miner. Res. 1989, 4:305-312.
43. Conaway H.H., Ransjo M., Lerner U.H. Prostaglandin-independent stimulation of bone resorption in mouse calvariae and in isolated rat osteoclasts by thyroid hormones (T4 and T3). Proc. Soc. Exp. Biol. Med. 1998, 217:153-161.
44. Biondi B., Cooper D.S. The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 2008, 29:76-131.
45. Pornprasertsuk S., Duarte W.R., Mochida Y., Yamauchi M. Lysyl hydroxylase-2b directs collagen cross-linking pathways in MC3T3-E1 cells. J. Bone Miner. Res. 2004, 19:1349-1355.
46. Zhao Y., Min C., Vora S.R., Trackman P.C., Sonenshein G.E., Kirsch K.H. The lysyl oxidase pro-peptide attenuates fibronectin-mediated activation of focal adhesion kinase and p130Cas in breast cancer cells. J. Biol. Chem. 2009, 284:1385-1393.